India Condom Market Key Takeaways

• The market is estimated at USD 239 million in 2025 and USD 260 million in 2026, reaching USD 417 million by 2032 with an 8.19% CAGR during 2026-32.
• Offline commercial retail leads by route to market, with an estimated 55% market share in 2026.
• Male/external condoms lead by product type, accounting for an estimated 98% share in 2026.
• The market is concentrated, with the top five companies collectively accounting for an estimated 76% share in 2026.

India Condom Market Size and Outlook

The India Condom Market was valued at an estimated USD 239 million in 2025 and is projected to reach USD 260 million in 2026. It is forecast to expand at a CAGR of around 8.19% during 2026–2032, reaching nearly USD 417 million by 2032.

Growth in condom sales in India is supported by commercial demand and headroom for wider adoption. CRISIL’s analysis of IQVIA OTC Audit data placed domestic condom-category sales approximately USD 246 million during the 12 months ended September 2024, compared with approximately USD 179 million in FY2022. Condom use among married Indian women reached 9.5% by 2021—almost twice the level five years earlier—while use among men remained around 10%. These indicators demonstrate improving acceptance but a considerable gap between availability and regular utilization.

Through 2032, the condom industry is expected to benefit from higher consumption and migration toward flavored, textured, ultra-thin and other differentiated formats. E-commerce and quick-commerce platforms should improve discreet access, assortment discovery and larger-pack purchasing. However, social stigma, rural price sensitivity and uneven retail availability will constrain adoption. The outlook therefore favors condom brands in India that combine affordable entry packs and broad pharmacy reach with dependable digital availability, privacy and differentiated premium offerings.

India Condom Market Key Indicators

• National AIDS Control Organisation’s 2025 Sankalak reported that prevention projects covered around 15.8 million people and managed 11.2 million sexually-transmitted/reproductive-tract infection episodes during FY2024–25. This programmatic reach sustains institutional demand and embeds free and social-marketing condom distribution within India’s broader HIV- and STI-prevention infrastructure.
• A May 2026 Government e Marketplace (GeM) tender issued for Central Medical Services Society requested 80.06 million free-supply condoms for the Family Planning Programme, with delivery scheduled within 180 days. The quantity demonstrates the continuing scale of government procurement alongside commercial condom sales in India and social-marketing distribution.
• The Telecom Regulatory Authority of India (TRAI) reported 1.09 billion internet subscribers and 1.07 billion broadband subscribers in India by March 2026. This extensive digital base increases the addressable audience for discreet product discovery, online payment and rapid fulfillment, supporting online commercial retail participation in the condom industry.
• Selected official manufacturer listings observed in August 2026 placed a 12-count latex pack at approximately USD 1.47 MRP and a 10-count premium non-latex pack at approximately USD 6.81. The spread illustrates substantial price and material differentiation among condom brands in India.
• A leading Indian supplier reported that modern trade and e-commerce rose from 11% to 15% of its consumer-healthcare sales in Q1 FY2027, supported by 38% channel growth; its condom portfolio also gained market share. This channel expansion improves product visibility, purchasing privacy and availability beyond conventional pharmacy and general-trade networks.

India Condom Market Manufacturing Capacity Analysis

India has a condom-manufacturing base spanning government-owned and private suppliers. In July 2025, HLL Lifecare reported annual production of 2.217 billion condoms across four manufacturing locations, including a staggering 1.246 billion units at Peroorkada. TTK Healthcare separately reports annual capacity of approximately 1.5 billion condoms across its manufacturing operations. This scale enables condom manufacturing companies to serve commercial brands, government procurement programs and institutional buyers while maintaining high-volume latex production.

Additional capacity is progressing but should remain distinguished from operational supply. Cupid Limited currently reports a combined annual installed capacity of 532 million condoms at its existing facility. In June 2026, the company stated that it planned to operationalize its Palava, Maharashtra, facility during the following quarter. The project is designed to add approximately 845 million condoms annually, taking planned capacity to over 1.37 billion condoms. The expansion should increase tender participation and supply flexibility while adding natural-rubber-latex and nitrile manufacturing capabilities. Through 2032, the condom industry’s manufacturing advantage will depend increasingly on quality certification, automated testing, flexible lines and dependable utilization rather than announced capacity alone.

India Condom Market Export-Import Analysis: Exports Outpace Imports 15.5 Times in 2025

India’s finished-condom trade remains export-oriented, reinforcing the country’s role as a manufacturing base for overseas markets. Export earnings increased from USD 69 million in 2022 to USD 83 million in 2025. Although earnings peaked in 2023 and corrected in 2024, a 18.57% recovery in 2025 renewed export momentum. Shipment volumes expanded faster at over 27% in 2025, indicating stronger overseas offtake but lower average realizations. This trade depth enables Indian condom manufacturing companies to pursue institutional tenders, contract production, private labels, and branded exports alongside condom sales in India.

Imports also increased from a small base, narrowing the export-to-import ratio from around 43 times in 2022 to 15.5 times in 2025. Nevertheless, India generated a USD 77.6 million finished-condom trade surplus in 2025. Imported condoms therefore supplement specific product and brand requirements rather than reshape the condom market in India. Separately, net import dependence in the wider natural-rubber-latex category indicates exposure to overseas input availability, currency movements, and procurement costs across India’s latex-consuming industries, including the condom industry.

India Condom Market Scope

India Condom Market Growth Drivers

Broader Reproductive-Health Awareness Expands the Addressable Consumer Base

Condom demand is broadening as India’s reproductive-health discourse increasingly emphasizes informed choice, preventive protection, and shared responsibility between partners. Greater awareness helps consumers recognize condoms as protection against both unintended pregnancy and sexually transmitted infections, while reducing the embarrassment associated with discussing or purchasing them. It can also bring women, couples, and first-time adult buyers more actively into purchase decisions. This broader participation allows condom brands in India to communicate around safety, consent, comfort, and mutual well-being rather than relying predominantly on male-oriented or pleasure-led messaging.

India’s current reproductive-health priorities support this transition. A 2025 UNFPA assessment identified expanded contraceptive choice, improved access for young and marginalized populations, social and behavior-change communication, and greater engagement of men and boys as key priorities. Outreach is also reaching consumers at scale. During 2025, UNFPA’s partnership with government systems delivered life-skills education to 6.4 million adolescents across more than 103,000 schools, twice the previous year’s reach. Its digital campaign portfolio, which included World Contraception Day, reached over 47.7 million people through social media. Continued exposure to reproductive-health information should gradually normalize protected sex, widen the paying consumer base, and support recurring condom sales in India through 2032.